| Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations C Bustamante, R Ochoa, C Asela, C Muskus Journal of Computer-Aided Molecular Design 33, 845-854, 2019 | 28 | 2019 |
| In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi C Bustamante, AF Díez-Mejía, N Arbeláez, MJ Soares, SM Robledo, ... Pathogens 11 (6), 616, 2022 | 2 | 2022 |
| Strategies to promote contraception use by female volunteers in Alzheimer’s Prevention Initiative Autosomal-Dominant Alzheimer’s Disease (API ADAD) Colombia trial C Bustamante, JF Martinez, A Navarro, M Lopera, G Villegas, S Duque, ... Clinical Trials, 17407745241264217, 2024 | | 2024 |
| Rational computational approaches to predict novel drug candidates against leishmaniasis C Bustamante, C Muskus, R Ochoa Annual Reports in Medicinal Chemistry 59, 137-187, 2022 | | 2022 |
| Construcción de una red farmacológica basada en simulaciones farmacodinámicas y farmacocinéticas in silico para la selección racional de medicamentos con actividad leishmanicida C Bustamante Toro | | 2017 |
